Skip to main content
OpenTrials
Completed

NCT Number: NCT03099954

Withings Pulse Wave Velocity and Blood Pressure Study

Measure pulse wave velocity stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Elevated Blood Pressure Behavior Behavioral Symptoms Cardiovascular Diseases Hypertension Mental Disorders Mental Stress Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Sleep Disorders Sleep Wake Disorders Stress, Psychological Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Scripps Translational Science Institute

La Jolla, California, 92037, United States

About this study

The study population will be an estimated 300 healthy adult subjects from the United States. This population will be approximately 150 men and 150 women. In order to obtain a relatively diverse age range of users (with varying levels of arterial stiffness), we hope to enroll participants across three age ranges entered in the Withings application by the user: 18-40 years, 41-60 years, and > 60 years. These spots will be filled by those that satisfy the inclusion/exclusion criteria on a first come, first served basis.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • User of a (1) Withings blood pressure cuff (2) Withings activity tracker and (3) Withings Body Cardio scale
  • User has measured their blood pressure at least once per week for the majority of weeks over the last three months.

Exclusion criteria

  • Aortic artery disease
  • Peripheral vascular disease
  • Atrial fibrillation
  • Weight > 396 lbs.
  • Pregnant women

Treatment and study plan

Primary outcomes

  1. Measure pulse wave velocity (PWV) stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.

    Time frame: Subjects will be expected to participate for a total of 16 weeks.

    The study population will be an estimated 300 healthy adult subjects from the United States who own a Withings blood pressure cuff, Withings activity tracker, and Withings Body Cardio scale and have measured their blood pressure at least once per week for the majority of weeks over the last three months.

Sponsors and collaborators

Lead sponsor

Scripps Translational Science Institute

Other

Collaborators

  • Withings

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Apr 4, 2017
Registry last updated
Mar 1, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.